Validation of Accexible as a Tool for Screening and Monitoring Depression.

Major depressive disorder (MDD) is a chronic disease with a prevalence around 8-12% and is considered one of the most debilitating disease worldwide.

A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness.

The present study has the objective of validating Accexible as a tool for Screening and Monitoring Depression.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Major Depressive Disorder (MDD) Depressive Disorder Depressive Disorder, Major Mental Disorders Mood Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Vall d'Hebron Institut de Investigación (VHIR)

Barcelona, 08035, Spain

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult 18-65 years of age.
Participants must have Spanish as their first language (able to speak and understand verbal messages).
Participants must have mobile phone with internet.
Participants must have the ability to understand AcceXible's basic instructions.
Participants must agree to participate in the study and have voluntarily signed the informed consent.

Exclusion criteria

for patients:

To have received a diagnosis of neurodegeneration.
To have significant vision problems that would affect the ability to perceive visual stimuli.
To have significant hearing problems that would affect the ability to understand verbal cues.
To be unable to give informed consent to participate in the study.

Treatment and study plan

AcceXible

Device

Speech Analysis

Primary outcomes

Prevalence of Depression

Time frame: An average of 1 year

questionnaire

Sponsors and collaborators

Lead sponsor

Accexible

Industry

Registry information

Official study title

Validación Del Sistema de Cribaje y Seguimiento de acceXible Para depresión.

Important dates

Study start: 2023
Primary completion: 2025
Study completion: 2025
First posted: Sep 21, 2023
Registry last updated: Mar 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed